Clinical Efficacy of Superfine Dispersed Lentinan (β-1,3-glucan) in Patients with Hepatocellular Carcinoma

Hepato-Gastroenterology

Volumn 56, Issue 90, 2009, Pages 437-441

  Isoda, Norio ^a   Eguchi, Yuichiro ^b   Nukaya, Haruhiko ^c   Hosho, Keiko ^d   Suga, Yasuyo ^e   Sugae, Tetsuya ^e   Nakazawa, Saburo ^f   Sugano, Kentaro ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SAGA UNIVERSITY HOSPITAL   (Japan)

^c CHUKYO HOSPITAL   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e AJINOMOTO CO INC   (Japan)

^f Yamashita Hospital   (Japan)

Author keywords

3 glucan; Hepatocellular carcinoma; Lentinan; ( 1; LNT binding monocytes; Median survival time; Superfine dispersed LNT

Indexed keywords

CD14 ANTIGEN; LENTINAN;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; FLOW CYTOMETRY; FOOD INTAKE; HUMAN; LIVER CELL CARCINOMA; MALE; MONOCYTE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; SAFETY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LENTINAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67649158338     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chihara G, Maeda YY, Hamuro J, Sakaki T, Fukuoka F: Inhibition of mouse sarcoma 180 by polysaccharide from Lentinus edodes (Berk) sing. Nature 1969; 222: 687-688.
2. Zakany J, Chihara G, Fachet J: Effect of lentinan on the production of migration inhibitory factor induced by syn-geneic tumor in mice. Int J Cancer 1980; 26: 783-788.
3. Suga T, Shiio T, Maeda YY, Chihara G: Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 1984; 44:5132-5137.
4. Ochiai T, Isono K, Suzuki T, Koide Y, Gunji Y, Naga-ta M, Ogawa N: Effect of immunotherapy with lentinan on patients' survival and immunological parameters in patients with gastric cancer: Results of a multi-centre randomized controlled study. Int J Immunother 1992; VIII: 161-169.
5. Taguchi T: Clinical efficacy of lentinan on patients with stomach cancer: End point results of a four-year follow-up survey. Cancer Detect Prev 1987; Suppl 1: 333-349.
6. Nakano H, Namatame K, Nemoto H, Motohashi H, Nishiyama K, Kumada K: A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: Effect on prolongation of survival and improvement of quality of hie. Hepa-to-Gastroenterol 1999; 46: 2662-2668.
7. Maeda YY, Chihara G: The effects of neonatal thymecto-my on the antitumor activity of lentinan, carboxymethyl-pachymaran and zymosan, and their effects on various immune responses. Int J Cancer 1973; 11:153-161.
8. Hamuro J, Rollinghoff M, Wagner H: Induction of cyto-toxic peritoneal exudates cells by T-cell immune adjuvants of the B (1-3) glucan-type lentinan and its analogues. Immunology 1980; 39: 551-559.
9. Yoshino S, Tabata T, Hazama S, Iizuka N, Yamamoto K, Hirayama M, Tangoku A, Oka M: Immunoregulatory effects of the antitumor polysaccharide lentinan on Thi/Th2 balance in patients with digestive cancer. Anticancer Res 2000; 20: 4707-4712.
10. Thornton BP, Vetvicka V, Pitman M, Goldman RC, Ross GD: Analysis of the sugar specificity and molecular location of the B-glucan-binding lectin site of complement receptor type 3 (CDllb/CD18). J Immunol 1996; 156: 1235-1246.
11. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Pomares LM, Wong SYC, Gordon S: Dectin-1 is a major B-glucan receptor on macrophages. J Exp Med 2002; 196: 407-412.
12. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM: Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197: 1107-1117.
13. Hamuro J, Murata Y, Suzuki M, Takatsuki F, Suga T: The triggering and healing of tumor stromal inflammatory reactions regulated by oxidative and reductive macrophages. Gann Monograph Cancer Res 1999; 48: 153-164.
14. Murata Y, Shimamura T, Tagami T, Takatsuki F, Hamuro J: The skewing to Thi induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2002; 2: 673-689.
15. Murata Y, Shimamura T, Hamuro J: The polarization of T(h)l/T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 2002; 14: 201-212.
16. Shen J, Ren H, Tomiyama MC, Suga Y, Suga T, Kuwano Y, Iiai T, Hatakeyama K, Abo T: Potentiation of intestinal immunity by micellary mushroom extracts. Biomed Res 2007; 28: 71-77.
17. Yamada J, Hamuro J, Hatanaka H, Hamabata K, Kinoshita S: Alleviation of seasonal allergic symptoms with superfine B-l,3-glucan: A randomized study. J Allergy Clin Immunol 2007; 119: 1119-1126.
18. Suga Y, Matsunaga Y, Sato Y, Murata M, Suga T: The importance of size for anti-tumor effects of beta-glucan. Bio-therapy 2005; 19: 273-278. (In Japanese with English abstract)
19. Fukuda H, Saijo N: National Cancer Institute-Common toxicity criteria (NCI-CTC version 2.0 Japanese JCOG version 2). Jpn J Cancer Chemother 2001; 28: 1993-2027. (In Japanese)
20. Kishida E, Sone Y, Shibata S, Misaki A: Preparation and immunochemical characterization of antibody to branched B-(l-3)-D-glucan of Volvariella volvasea, and its use in studies of antitumor actions. Agric Biol Chem 1989; 53: 1849-1859.
21. Nimura H, Mitsumori N, Tsukagoshi S, Nakajima M, Atomi Y, Suzuki S, Kusano M, Yoshiyuki T, Tokuna-ga A: Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer. Jpn J Cancer Chemother 2003; 30: 1289-1296. (In Japanese with English abstract)
22. Suga Y, Takai K, Kondo H, Sano A, Sugita N, Hazama S, Yoshino S, Suga T, Oka M, Murata M: Development of method to distinguish lentinan binding ability of human peripheral blood monocytes. Biotherapy 2006; 20: 79-83. (In Japanese with English abstract)
23. Willment JA, Gordon S, Brown GD: Characterization of the human B-glucan receptor and its alternatively spliced isoforms. J Biol Chem 2001; 276: 43818-43823.
24. Heinsbroek SEM, Taylor PR, Rosas M, Willment AJ, Williams DL, Gordon S, Brown GD: Expression of functionally different dectin-1 isoforms by murine macrophages. J Immunol 2006; 176: 5513-5518.